Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02042456 · ClinicalTrials.gov registry record
Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts
A clinical trial, sponsored by GE Healthcare.
- Terminated
- Registry status
- 124
- Enrollment target
NCT02042456 is a clinical trial that was terminated before completion, run by GE Healthcare. The registered enrollment target is 124 participants.
The verdict
NCT02042456 was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- 124 participants
- Enrollment target
Study Summary
This study is investigating whether automated whole breast ultrasound can improve detection of cancer in breast cancer screening when used as a supplement to mammography or as a supplement to digital breast tomosynthesis
Interventions
- DEVICE Full Field Digital Mammography
- DEVICE Digital Breast Tomosynthesis
- DEVICE Automated Whole Breast Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02042456
The ClinicalTrials.gov registry entry for NCT02042456 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Full Field Digital Mammography is the first listed.
NCT02042456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02042456 about?
NCT02042456 is a clinical study titled "Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense Breasts". This study is investigating whether automated whole breast ultrasound can improve detection of cancer in breast cancer screening when used as a supplement to mammography or as a supplement to digital breast tomosynthesis
What is the current status of trial NCT02042456?
This trial is currently terminated. The enrollment target is 124 participants. The study started on 2014-04. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02042456?
The interventions under investigation include: Full Field Digital Mammography (DEVICE), Digital Breast Tomosynthesis (DEVICE), Automated Whole Breast Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02042456?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.